Literature DB >> 23541795

Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.

Anthony B Costales1, Andrea M Milbourne, Helen E Rhodes, Mark F Munsell, John J Wallbillich, Jubilee Brown, Michael Frumovitz, Lois M Ramondetta, Kathleen M Schmeler.   

Abstract

OBJECTIVE: Cervical adenocarcinoma in situ (AIS) is increasing in incidence among reproductive-age women. Cervical conization is an alternative to hysterectomy that allows future fertility, however reports regarding the risk of residual AIS and underlying adenocarcinoma are conflicting. The purpose of this study was to determine the outcomes of a large cohort of women treated for AIS.
METHODS: The medical records of 180 women with cervical AIS evaluated at the University of Texas MD Anderson Cancer Center and its outlying clinics between 1983 and 2011 were reviewed for demographic information, treatment history, pathologic findings and outcomes.
RESULTS: The mean age at diagnosis was 33.8years (range 17.6-76.1years). 172 of the 180 women had at least one cone biopsy performed, with 110 (64.0%) undergoing a cold knife cone (CKC), and 62 (36.0%) undergoing a loop electrosurgical excision procedure (LEEP) as their initial method of treatment. Positive margins were noted in 35.0% of patients undergoing CKC compared with 55.6% undergoing LEEP (p=0.017). 71 patients ultimately underwent hysterectomy with residual disease noted in 10 patients (14.1%), 8 patients (11.3%) with residual AIS and 2 patients (2.8%) with invasive carcinoma. Of the 101 patients who did not undergo hysterectomy, 2 patients (2.0%) developed recurrent AIS at a median of 27.5months (range 18-37months) from the last cone, and none developed invasive carcinoma.
CONCLUSION: Patients undergoing conservative management for AIS with cervical conization alone should be monitored closely and counseled regarding the potential risks of residual and recurrent disease, even when negative cone margins are obtained.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23541795      PMCID: PMC3822524          DOI: 10.1016/j.ygyno.2013.03.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  30 in total

1.  Adenocarcinoma in situ of the cervix: a prospective study of conization as definitive treatment.

Authors:  Erik Soegaard Andersen; Karsten Nielsen
Journal:  Gynecol Oncol       Date:  2002-09       Impact factor: 5.482

2.  Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.

Authors:  T R Denehy; C A Gregori; J L Breen
Journal:  Obstet Gynecol       Date:  1997-07       Impact factor: 7.661

3.  Primary adenocarcinoma of the cervix.

Authors:  T K HEPLER; M B DOCKERTY; L M RANDALL
Journal:  Am J Obstet Gynecol       Date:  1952-04       Impact factor: 8.661

4.  Can cervical adenocarcinoma in situ be safely managed by conization alone?

Authors:  H G Muntz
Journal:  Gynecol Oncol       Date:  1996-06       Impact factor: 5.482

Review 5.  Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.

Authors:  D D Im; L R Duska; N B Rosenshein
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

6.  Adenocarcinoma in situ of the uterine cervix: management and outcome.

Authors:  T Widrich; A W Kennedy; T M Myers; W R Hart; S Wirth
Journal:  Gynecol Oncol       Date:  1996-06       Impact factor: 5.482

Review 7.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

8.  Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.

Authors:  Shawna L Bull-Phelps; Elizabeth I O Garner; Christine S Walsh; Paola A Gehrig; David S Miller; John O Schorge
Journal:  Gynecol Oncol       Date:  2007-08-08       Impact factor: 5.482

9.  Pregnancy outcome in women before and after cervical conisation: population based cohort study.

Authors:  Susanne Albrechtsen; Svein Rasmussen; Steinar Thoresen; Lorentz M Irgens; Ole Erik Iversen
Journal:  BMJ       Date:  2008-09-18

Review 10.  Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.

Authors:  M Arbyn; M Kyrgiou; C Simoens; A O Raifu; G Koliopoulos; P Martin-Hirsch; W Prendiville; E Paraskevaidis
Journal:  BMJ       Date:  2008-09-18
View more
  6 in total

Review 1.  Atypical glandular cells (AGC): Cytology of glandular lesions of the uterine cervix.

Authors:  Mir Yousufuddin Ali Khan; Sudeshna Bandyopadhyay; Ahmed Alrajjal; Moumita Saha Roy Choudhury; Rouba Ali-Fehmi; Vinod B Shidham
Journal:  Cytojournal       Date:  2022-04-30       Impact factor: 2.345

2.  Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.

Authors:  Jiangrong Wang; Bengt Andrae; Karin Sundström; Peter Ström; Alexander Ploner; K Miriam Elfström; Lisen Arnheim-Dahlström; Joakim Dillner; Pär Sparén
Journal:  BMJ       Date:  2016-02-11

Review 3.  Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.

Authors:  Yanming Jiang; Changxian Chen; Li Li
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 4.  Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.

Authors:  Deanna Teoh; Fernanda Musa; Ritu Salani; Warner Huh; Edward Jimenez
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

5.  Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow-up.

Authors:  Karen Belkić; Sonia Andersson; Susanna Alder; Miriam Mints; David Megyessi
Journal:  Oncol Lett       Date:  2022-08-25       Impact factor: 3.111

6.  Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.

Authors:  Huimin Bai; Jun Liu; Qiuxi Wang; Ying Feng; Tong Lou; Shuzhen Wang; Yue Wang; Mulan Jin; Zhenyu Zhang
Journal:  BMC Cancer       Date:  2018-04-24       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.